Next Article in Journal
Selenium and the 15kDa Selenoprotein Impact Colorectal Tumorigenesis by Modulating Intestinal Barrier Integrity
Next Article in Special Issue
Adipocyte Biology from the Perspective of In Vivo Research: Review of Key Transcription Factors
Previous Article in Journal
The Effects of Sperm and Seminal Fluid of Immunized Male Mice on In Vitro Fertilization and Surrogate Mother–Embryo Interaction
Article

TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes

1
Curtin Medical School, Curtin University, Bentley, WA 6102, Australia
2
Curtin Health and Innovation Research Institute, Curtin University, Perth, WA 6845, Australia
3
Curtin Institute for Computation, Curtin University, Perth, WA 6845, Australia
4
Dobney Hypertension Centre, School of Biomedical Sciences—Royal Perth Hospital Unit, University of Western Australia, Perth, WA 6009, Australia
5
Department of Biochemistry and Pharmacology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
6
School of Chemistry, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia
7
Department of Cardiology, Royal Perth Hospital, Perth, WA 6000, Australia
8
Department of Nephrology, Royal Perth Hospital, Perth, WA 6000, Australia
9
Department of Medicine, Royal Perth Hospital, Perth, WA 6000, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Jean-françois Tanti
Int. J. Mol. Sci. 2021, 22(19), 10647; https://doi.org/10.3390/ijms221910647
Received: 24 August 2021 / Revised: 24 September 2021 / Accepted: 28 September 2021 / Published: 30 September 2021
(This article belongs to the Special Issue Mechanisms of Insulin Resistance and Adipose Tissue Dysfunction)
Obesity is one of the most prevalent metabolic diseases in the Western world and correlates directly with glucose intolerance and insulin resistance, often culminating in Type 2 Diabetes (T2D). Importantly, our team has recently shown that the TNF superfamily (TNFSF) member protein, TNFSF14, has been reported to protect against high fat diet induced obesity and pre-diabetes. We hypothesized that mimics of TNFSF14 may therefore be valuable as anti-diabetic agents. In this study, we use in silico approaches to identify key regions of TNFSF14 responsible for binding to the Herpes virus entry mediator and Lymphotoxin β receptor. In vitro evaluation of a selection of optimised peptides identified six potentially therapeutic TNFSF14 peptides. We report that these peptides increased insulin and fatty acid oxidation signalling in skeletal muscle cells. We then selected one of these promising peptides to determine the efficacy to promote metabolic benefits in vivo. Importantly, the TNFSF14 peptide 7 reduced high fat diet-induced glucose intolerance, insulin resistance and hyperinsulinemia in a mouse model of obesity. In addition, we highlight that the TNFSF14 peptide 7 resulted in a marked reduction in liver steatosis and a concomitant increase in phospho-AMPK signalling. We conclude that TNFSF14-derived molecules positively regulate glucose homeostasis and lipid metabolism and may therefore open a completely novel therapeutic pathway for treating obesity and T2D. View Full-Text
Keywords: Type 2 Diabetes; obesity; TNFSF14; LIGHT; therapy; metabolic syndrome Type 2 Diabetes; obesity; TNFSF14; LIGHT; therapy; metabolic syndrome
Show Figures

Figure 1

MDPI and ACS Style

Agostino, M.; Rooney, J.; Herat, L.; Matthews, J.; Simonds, A.; Northfield, S.E.; Hopper, D.; Schlaich, M.P.; Matthews, V.B. TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes. Int. J. Mol. Sci. 2021, 22, 10647. https://doi.org/10.3390/ijms221910647

AMA Style

Agostino M, Rooney J, Herat L, Matthews J, Simonds A, Northfield SE, Hopper D, Schlaich MP, Matthews VB. TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes. International Journal of Molecular Sciences. 2021; 22(19):10647. https://doi.org/10.3390/ijms221910647

Chicago/Turabian Style

Agostino, Mark, Jennifer Rooney, Lakshini Herat, Jennifer Matthews, Allyson Simonds, Susan E. Northfield, Denham Hopper, Markus P. Schlaich, and Vance B. Matthews. 2021. "TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes" International Journal of Molecular Sciences 22, no. 19: 10647. https://doi.org/10.3390/ijms221910647

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop